Multiple System Atrophy Market Overview 2026 and Forecast till 2035
The global multiple system atrophy market was valued at USD 150.1 million in 2025 and is anticipated to reach USD 230.8 million by 2035, growing at a CAGR of 4.9% during the forecast period.
Multiple System Atrophy Industry Demand
Multiple System Atrophy (MSA) is a rare, progressive neurodegenerative disorder characterized by autonomic dysfunction, parkinsonism, and cerebellar ataxia. The MSA market encompasses symptomatic therapies, supportive care products and services, diagnostics, and an emerging pipeline of disease-modifying treatments.
Demand drivers include: